![Alcon to Launch Pataday, the Eye Allergy Drop with the #1 Doctor-Prescribed Active Ingredient, following FDA Approval of OTC Switch | Business Wire Alcon to Launch Pataday, the Eye Allergy Drop with the #1 Doctor-Prescribed Active Ingredient, following FDA Approval of OTC Switch | Business Wire](https://mms.businesswire.com/media/20200217005063/en/773751/4/webready480.jpg)
Alcon to Launch Pataday, the Eye Allergy Drop with the #1 Doctor-Prescribed Active Ingredient, following FDA Approval of OTC Switch | Business Wire
![Alcon to Launch Pataday, the Eye Allergy Drop with the #1 Doctor-Prescribed Active Ingredient, following FDA Approval of OTC Switch | Business Wire Alcon to Launch Pataday, the Eye Allergy Drop with the #1 Doctor-Prescribed Active Ingredient, following FDA Approval of OTC Switch | Business Wire](https://mms.businesswire.com/media/20200217005063/en/773752/5/TWICE_DAILY_SINGLE_FRONT_.jpg)
Alcon to Launch Pataday, the Eye Allergy Drop with the #1 Doctor-Prescribed Active Ingredient, following FDA Approval of OTC Switch | Business Wire
![Alcon Announces FDA Approval of the OTC Switch of Pataday Once Daily Relief Extra Strength | Alcon.com Alcon Announces FDA Approval of the OTC Switch of Pataday Once Daily Relief Extra Strength | Alcon.com](https://mms.businesswire.com/media/20200714005390/en/805045/4/3D_PTD_Family_Lineup.jpg)